Internet Delivered CBT for Body Dysmorphic Disorder

August 15, 2017 updated by: Christian Rück, Karolinska Institutet

Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial

To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
    • Huddinge
      • Stockholm, Huddinge, Sweden, 141 86
        • M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • outpatient
  • ≥ 18 years
  • primary diagnosis of BDD according to the DSM-5
  • BDD-YBOCS ≥20
  • regular access to a computer with Internet access and skills to use the web.

Exclusion Criteria:

  • psychotropic medication changes within two months prior to the treatment,
  • completed CBT for BDD within the last 12 months,
  • other primary axis I diagnosis
  • current substance dependence
  • lifetime bipolar disorder or psychosis
  • suicidal ideation
  • Axis II diagnosis that could jeopardize treatment participation,
  • other current psychological treatment that could affect BDD symptoms
  • A serious medical illness that precludes participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Supportive therapy
Behavioral: Supportive therapy
Experimental: Cognitive behavior therapy
Behavioral: Cognitive behavior therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)
Time Frame: Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)
Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)

Secondary Outcome Measures

Outcome Measure
Time Frame
The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)
Time Frame: Change in MADRS-S from baseline (week 0) to post-treatment (week 12)
Change in MADRS-S from baseline (week 0) to post-treatment (week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2013

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

November 18, 2013

First Submitted That Met QC Criteria

December 12, 2013

First Posted (Estimate)

December 13, 2013

Study Record Updates

Last Update Posted (Actual)

August 18, 2017

Last Update Submitted That Met QC Criteria

August 15, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BDD RCT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Dysmorphic Disorder

Clinical Trials on Supportive therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe